Abstract: A system and method is provided for visual traceability of requirements for products. The system may include a processor configured to generate a user interface through a display device that outputs a listing of at least a portion of a plurality of requirements for a product based on data stored in a data store that specifies associations between requirements and one or more of a plurality of components included in the product. The processor may receive a first input through at least one input device that is representative of a first selection of at least one of the plurality of requirements.

Abstract: The present invention in various aspects and embodiments provides methods and formulations for treating inflammatory conditions of the skin and/or conditions involving compromised skin barrier function. Such diseases include blistering diseases of the skin, hereditary defects in skin barrier function, hyperproliferative conditions involving the skin, conditions associated with aging or damaged skin, immunological disorders involving the skin, among others.

Abstract: Provided is a system for protecting submerged components of a watercraft from collision with a submerged object or a floor of a body of water. The system includes a depth sensor configured to measure a water depth beneath the watercraft, an actuated mechanism configured to adjust a depth of at least one of the submerged components, and a controller in communication with the depth sensor and the actuated mechanism. The controller is operable to receive the measured water depth and control the actuated mechanism to adjust the depth of the at least one submerged component as a function of the measured water depth to prevent the at least one submerged component from colliding with the submerged object or floor of the body of water.

Abstract: The present invention provides a stabilized hypohalous acid solution (or formulation thereof), which may be conveniently packaged for sale, or stored for later use on demand. The invention further provides methods of making the stabilized hypohalous acid solutions, as well as methods of use for disinfecting mammalian tissue, including wounds and burns, and treating skin irritations, among other uses.

Abstract: The present invention in various aspects and embodiments provides methods and formulations for treating inflammatory conditions of the skin and/or conditions involving compromised skin barrier function. Such diseases include blistering diseases of the skin, hereditary defects in skin barrier function, hyperproliferative conditions involving the skin, conditions associated with aging or damaged skin, immunological disorders involving the skin, among others.

Abstract: The present invention provides methods for treating conditions that involve infection and/or inflammation, including acute and chronic inflammation, as well as delayed-type and immediate-type hypersensitivity. The invention in various embodiments provides methods for treating microbial infection and the associated inflammatory response, as well methods for treating inflammatory conditions that spawn or are susceptible to secondary microbial infection. Further, the invention provides methods for treating inflammation, such as chronic inflammation, without any associated microbial infection.

Abstract: The present invention in various aspects and embodiments provides methods and formulations for treating inflammatory conditions of the skin and/or conditions involving compromised skin barrier function. Such diseases include blistering diseases of the skin, hereditary defects in skin barrier function, hyperproliferative conditions involving the skin, conditions associated with aging or damaged skin, immunological disorders involving the skin, among others.

Abstract: A system and method is provided for visual traceability of requirements for products. The system may include a processor configured to generate a user interface through a display device that outputs a listing of at least a portion of a plurality of requirements for a product based on data stored in a data store that specifies associations between requirements and one or more of a plurality of components included in the product. The processor may receive a first input through at least one input device that is representative of a first selection of at least one of the plurality of requirements.

Abstract: The present invention provides a stabilized hypohalous acid solution (or formulation thereof), which may be conveniently packaged for sale, or stored for later use on demand. The invention further provides methods of making the stabilized hypohalous acid solutions, as well as methods of use for disinfecting mammalian tissue, including wounds and burns, and treating skin irritations, among other uses.

Abstract: The present invention provides methods for treating conditions that involve infection and/or inflammation, including acute and chronic inflammation, as well as delayed-type and immediate-type hypersensitivity. The invention in various embodiments provides methods for treating microbial infection and the associated inflammatory response, as well methods for treating inflammatory conditions that spawn or are susceptible to secondary microbial infection.

Abstract: The present invention provides methods for treating conditions that involve infection and/or inflammation, including acute and chronic inflammation, as well as delayed-type and immediate-type hypersensitivity. The invention in various embodiments provides methods for treating microbial infection and the associated inflammatory response, as well methods for treating inflammatory conditions that spawn or are susceptible to secondary microbial infection. Further, the invention provides methods for treating inflammation, such as chronic inflammation, without any associated microbial infection.

Abstract: The present invention provides a stabilized hypohalous acid solution (or formulation thereof), which may be conveniently packaged for sale, or stored for later use on demand. The invention further provides methods of making the stabilized hypohalous acid solutions, as well as methods of use for disinfecting mammalian tissue, including wounds and burns, and treating skin irritations, among other uses.

Abstract: The present invention provides a method for treating, preventing, or managing local inflammatory symptoms, including symptoms associated with acute or chronic inflammation, and particularly for conditions that are characterized by an underlying immunological disease or condition. The invention further provides methods for controlling inflammatory processes relating to cancer and the microbial flora.

Abstract: The present invention in various aspects and embodiments provides methods and formulations for treating inflammatory conditions of the skin and/or conditions involving compromised skin barrier function. Such diseases include blistering diseases of the skin, hereditary defects in skin barrier function, hyperproliferative conditions involving the skin, conditions associated with aging or damaged skin, immunological disorders involving the skin, among others.

Abstract: The present invention relates to hypochlorous acid compositions and their use in therapy for cancer patients.

Abstract: Provided is a system for protecting submerged components of a watercraft from collision with a submerged object or a floor of a body of water. The system includes a depth sensor configured to measure a water depth beneath the watercraft, an actuated mechanism configured to adjust a depth of at least one of the submerged components, and a controller in communication with the depth sensor and the actuated mechanism. The controller is operable to receive the measured water depth and control the actuated mechanism to adjust the depth of the at least one submerged component as a function of the measured water depth to prevent the at least one submerged component from colliding with the submerged object or floor of the body of water.

Abstract: The present invention provides a stabilized hypohalous acid solution (or formulation thereof), which may be conveniently packaged for sale, or stored for later use on demand. The invention further provides methods of making the stabilized hypohalous acid solutions, as well as methods of use for disinfecting mammalian tissue, including wounds and burns, and treating skin irritations, among other uses.

Abstract: The present invention provides a stabilized hypohalous acid solution (or formulation thereof), which may be conveniently packaged for sale, or stored for later use on demand. The invention further provides methods of making the stabilized hypohalous acid solutions, as well as methods of use for disinfecting mammalian tissue, including wounds and burns, and treating skin irritations, among other uses.

Abstract: The present invention provides a stabilized hypohalous acid solution (or formulation thereof), which may be conveniently packaged for sale, or stored for later use on demand. The invention further provides methods of making the stabilized hypohalous acid solutions, as well as methods of use for disinfecting mammalian tissue, including wounds and burns, and treating skin irritations, among other uses.

Abstract: The present invention provides methods for treating conditions that involve infection and/or inflammation, including acute and chronic inflammation, as well as delayed-type and immediate-type hypersensitivity. The invention in various embodiments provides methods for treating microbial infection and the associated inflammatory response, as well methods for treating inflammatory conditions that spawn or are susceptible to secondary microbial infection.